Magnesium pyridoxal 5-phosphate glutamate

Magnesium pyridoxal 5-phosphate glutamate
Clinical data
Trade namesSedalipid
ATC code
Identifiers
  • (2S)-2,5-diamino-5-oxopentanoic acid;
    (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H20N3O9P
Molar mass393.289 g·mol−1
3D model (JSmol)
  • O=C(N)CC[C@H](N)C(=O)O.O=P(O)(O)OCc1cnc(c(O)c1C=O)C
  • InChI=1S/C8H10NO6P.C5H10N2O3/c1-5-8(11)7(3-10)6(2-9-5)4-15-16(12,13)14;6-3(5(9)10)1-2-4(7)8/h2-3,11H,4H2,1H3,(H2,12,13,14);3H,1-2,6H2,(H2,7,8)(H,9,10)/t;3-/m.0/s1 checkY
  • Key:BCARVEADLDZBJT-HVDRVSQOSA-N checkY
  (verify)

Magnesium pyridoxal 5-phosphate glutamate (trade name Sedalipid) is a hypolipidemic agent.[1]

References

  1. ^ Schuitemaker GE, van der Pol GA, Aretz CP, Dinant GJ (2001). "A placebo-controlled, double-blind, randomised trial of magnesium-pyridoxal-5'-phosphate-glutamate for hypercholesterolaemia and other clinical-chemical risk factors of cardiovascular disease in a primary care setting". Eur. J. Clin. Pharmacol. 56 (12): 857–63. doi:10.1007/s002280000247. PMID 11317472.


Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.